Last reviewed · How we verify
NCT07027267: Gaia
Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery
NA trial testing Implantation of Spirair device into the middle turbinates in Sinus Endoscopic Surgery in 50 participants. Participants enrolled and being followed up; not accepting new ones.
5 May 2026
Quick facts
| Lead sponsor | Spirair, Inc |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 4 August 2025 |
| Primary completion | 5 May 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- Implantation of Spirair device into the middle turbinates
- TurbAlign
Conditions studied
- Sinus Endoscopic Surgery — all drugs for Sinus Endoscopic Surgery →
- Turbinate — all drugs for Turbinate →
Sponsor
Spirair, Inc — full company profile →
Who can join
Adults 18 to 70, any sex, with Sinus Endoscopic Surgery or Turbinate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07027267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Spirair, Inc trials
Trials by the same sponsor.
- NCT05967169 — EFS of Bioabsorbable Implant for NSD · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07027267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Spirair, Inc
- Last refreshed: 30 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07027267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing